226 related articles for article (PubMed ID: 28394262)
41. DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression.
Tong WM; Hande MP; Lansdorp PM; Wang ZQ
Mol Cell Biol; 2001 Jun; 21(12):4046-54. PubMed ID: 11359911
[TBL] [Abstract][Full Text] [Related]
42. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.
Saintigny Y; Lopez BS
Oncogene; 2002 Jan; 21(3):488-92. PubMed ID: 11821962
[TBL] [Abstract][Full Text] [Related]
43. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
Tomicic MT; Christmann M; Kaina B
Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
[TBL] [Abstract][Full Text] [Related]
44. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
[TBL] [Abstract][Full Text] [Related]
45. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response.
Zhao M; Wang T; Gleber-Netto FO; Chen Z; McGrail DJ; Gomez JA; Ju W; Gadhikar MA; Ma W; Shen L; Wang Q; Tang X; Pathak S; Raso MG; Burks JK; Lin SY; Wang J; Multani AS; Pickering CR; Chen J; Myers JN; Zhou G
Nat Commun; 2024 Jan; 15(1):180. PubMed ID: 38167338
[TBL] [Abstract][Full Text] [Related]
46. Mutant p53 Gain-of-Function in the Spotlight: Are We Suffering a GOF Delusion?
Lane DP
Cancer Discov; 2024 Feb; 14(2):211-213. PubMed ID: 38327191
[TBL] [Abstract][Full Text] [Related]
47. The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.
Vaughan CA; Singh S; Subler MA; Windle JJ; Inoue K; Fry EA; Pillappa R; Grossman SR; Windle B; Andrew Yeudall W; Deb SP; Deb S
Nat Commun; 2021 Jan; 12(1):704. PubMed ID: 33514736
[TBL] [Abstract][Full Text] [Related]
48. Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.
Schulz-Heddergott R; Moll UM
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29875343
[TBL] [Abstract][Full Text] [Related]
49. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
Shetzer Y; Molchadsky A; Rotter V
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27235476
[TBL] [Abstract][Full Text] [Related]
50. Sex- and mutation-specific p53 gain-of-function activity in gliomagenesis.
Rockwell NC; Yang W; Warrington NM; Staller MV; Griffith M; Griffith OL; Gurnett CA; Cohen BA; Baldridge D; Rubin JB
Cancer Res Commun; 2021 Dec; 1(3):148-163. PubMed ID: 34957471
[TBL] [Abstract][Full Text] [Related]
51. Mutant p53 oncogenicity: dominant-negative or gain-of-function?
Stein Y; Aloni-Grinstein R; Rotter V
Carcinogenesis; 2020 Dec; 41(12):1635-1647. PubMed ID: 33159515
[TBL] [Abstract][Full Text] [Related]
52. Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants.
Chachad D; Patel LR; Recio CV; Pourebrahim R; Whitley EM; Wang W; Su X; Xu A; Lee DF; Lozano G
Cancer Res; 2023 Jul; 83(14):2297-2311. PubMed ID: 37205631
[TBL] [Abstract][Full Text] [Related]
53. Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteins.
Tutuska K; Parrilla-Monge L; Di Cesare E; Nemajerova A; Moll UM
Cell Death Dis; 2020 Apr; 11(4):274. PubMed ID: 32332697
[TBL] [Abstract][Full Text] [Related]
54. Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.
Olszewski MB; Pruszko M; Snaar-Jagalska E; Zylicz A; Zylicz M
Int J Oncol; 2019 Apr; 54(4):1168-1182. PubMed ID: 30968154
[TBL] [Abstract][Full Text] [Related]
55. Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype.
Ma S; McGuire MH; Mangala LS; Lee S; Stur E; Hu W; Bayraktar E; Villar-Prados A; Ivan C; Wu SY; Yokoi A; Dasari SK; Jennings NB; Liu J; Lopez-Berestein G; Ram P; Sood AK
Cell Rep; 2021 Feb; 34(6):108726. PubMed ID: 33567287
[TBL] [Abstract][Full Text] [Related]
56. Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells.
Wang Z; Burigotto M; Ghetti S; Vaillant F; Tan T; Capaldo BD; Palmieri M; Hirokawa Y; Tai L; Simpson DS; Chang C; Huang AS; Lieschke E; Diepstraten ST; Kaloni D; Riffkin C; Huang DCS; Li Wai Suen CSN; Garnham AL; Gibbs P; Visvader JE; Sieber OM; Herold MJ; Fava LL; Kelly GL; Strasser A
Cancer Discov; 2024 Feb; 14(2):362-379. PubMed ID: 37877779
[TBL] [Abstract][Full Text] [Related]
57. Illuminating p53 function in cancer with genetically engineered mouse models.
Garcia PB; Attardi LD
Semin Cell Dev Biol; 2014 Mar; 27():74-85. PubMed ID: 24394915
[TBL] [Abstract][Full Text] [Related]
58. The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells.
Klemke L; Fehlau CF; Winkler N; Toboll F; Singh SK; Moll UM; Schulz-Heddergott R
Front Oncol; 2021; 11():642603. PubMed ID: 34178628
[TBL] [Abstract][Full Text] [Related]
59. Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells.
Saini H; Hakeem I; Mukherjee S; Chowdhury S; Chowdhury R
J Oncol; 2019; 2019():6164807. PubMed ID: 30723502
[TBL] [Abstract][Full Text] [Related]
60. Morphofunctional Differences of Micronuclei in Cultures of Human p53-Positive and p53-Negative Tumor Cells.
Sutyagina OI; Kisurina-Evgenieva OP
Bull Exp Biol Med; 2019 Oct; 167(6):813-817. PubMed ID: 31656006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
